Getinge AB förlänger uppköpserbjudande


Getinge AB förlänger uppköpserbjudande 

22 januari 2009 

Getinge AB (STO: GETIB) (“Getinge”) har idag förlängt det tidigare
offentliggjorda uppköpserbjudandet (”Erbjudandet”) avseende samtliga utestående
aktier i Datascope Corp. (NASDAQ: DSCP) (“Datascope”). Förlängningen sträcker
sig till och med den 29 januari 2009, med möjlighet till ytterligare
förlängning. Samtliga övriga villkor för Erbjudandet, inklusive priset USD 53
per aktie, kvarstår oförändrade. 

Per den 21 januari 2009 har Erbjudandet accepterats av aktieägare som
tillsammans innehar 14,959,485 aktier i Datascope, vilket motsvarar cirka 93 %
av det totala antalet utestående aktier i bolaget. 

För mer information kontakta: 
Getinge AB 
Ulf Grunander, Ekonomidirektör 
035-15 55 00

Notes for Editors 
Getinge is a leading global provider of equipment and systems that contribute to
quality enhancement and cost efficiency within healthcare and life sciences.
Equipment, service and technologies are supplied under the brands ArjoHuntleigh
for patient handling and hygiene, disinfection, DVT prevention, medical beds,
therapeutic surfaces and diagnostics, GETINGE for infection control and
prevention within healthcare and life science and MAQUET for surgical
workplaces, cardiovascular and critical care. For news releases, webcasts and
other information about Getinge, please visit Getinge's website,
http://www.getingegroup.com. 

Datascope is the global leader of intra-aortic balloon counterpulsation and a
diversified medical device company that develops, manufactures and markets
proprietary products for clinical health care markets in interventional
cardiology, cardiovascular and vascular surgery and critical care. The Company's
products are sold throughout the world through direct sales representatives and
independent distributors. Founded in 1964, Datascope is headquartered in
Montvale, New Jersey. For news releases, webcasts and other information about
Datascope, please visit Datascope's website, http://www.datascope.com.

Attachments

01222035.pdf